drugset / Trial / NCT06325930
A Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-HU6
NaSingle-groupOpen-labelTreatment
Summary
This is a single-center, non-randomized, open-label Phase 1 study to characterize the absorption, metabolism, excretion, mass balance, pharmacokinetics (PK), safety and tolerability of HU6 following administration of a single dose of \[14C\]-HU6 in a fed state with a standard meal administered approximately 15 minutes prior to dosing.
Timeline
- Start
- 2024-03-26
- Primary completion
- 2024-05-07
- Completion
- 2024-05-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HU6 | Unknown | — | Oral |
Indications
No indication recorded.